Symbols / WST Stock $306.16 -1.14% West Pharmaceutical Services, Inc.

Healthcare • Medical Instruments & Supplies • United States • NYQ
WST (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Eric M. Green
Exch · Country NYQ · United States
Market Cap 21.63B
Enterprise Value 21.43B
Income 542.70M
Sales 3.22B
FCF (ttm) 275.66M
Book/sh 44.11
Cash/sh 7.38
Employees 10,800
Insider 10d —
IPO Mar 17, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 11.50%
P/E 40.99
Forward P/E 32.05
PEG 3.73
P/S 6.72
P/B 6.94
P/C —
EV/EBITDA 24.63
EV/Sales 6.65
Quick Ratio 1.81
Current Ratio 2.71
Debt/Eq 10.73
LT Debt/Eq —
EPS (ttm) 7.47
EPS next Y 9.55
EPS Growth 56.10%
Revenue Growth 21.00%
EPS Gr Q/Q 54.60%
Rev Gr Q/Q —
Earnings (next) 2026-07-23
Earnings (prior) 2026-04-23
ROA 11.21%
ROE 19.13%
ROIC —
Gross Margin 36.28%
Oper. Margin 21.70%
Profit Margin 16.85%
Shs Outstand 70.65M
Shs Float 70.15M
Insider Own 0.64%
Instit Own 99.21%
Short Float 4.38%
Short Ratio 3.18
Short Interest 2.66M
52W High 322.34
vs 52W High -5.02%
52W Low 202.79
vs 52W Low 50.97%
Beta 1.15
Impl. Vol. 40.30%
Rel Volume 1.00
Avg Volume 978.02K
Volume 973.74K
Target (mean) $349.85
Tgt Median $350.00
Tgt Low $310.00
Tgt High $400.00
# Analysts 13
Recom Buy
Prev Close $309.70
Price $306.16
Change -1.14%
About

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$349.85
Mean price target
2. Current target
$306.16
Latest analyst target
3. DCF / Fair value
$70.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$306.16
Low
$310.00
High
$400.00
Mean
$349.85

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 main Barclays Equal-Weight → Equal-Weight $275
2026-02-13 main Barclays Equal-Weight → Equal-Weight $265
2026-02-03 main Evercore ISI Group Outperform → Outperform $320
2025-12-02 init Morgan Stanley — → Equal-Weight $285
2025-10-29 init TD Cowen — → Buy $350
2025-10-27 main Barclays Equal-Weight → Equal-Weight $325
2025-10-24 main UBS Buy → Buy $355
2025-10-24 main Keybanc Overweight → Overweight $350
2025-10-23 main Evercore ISI Group Outperform → Outperform $390
2025-10-02 main Barclays Equal-Weight → Equal-Weight $275
2025-09-15 init Rothschild & Co — → Buy $311
2025-07-25 main UBS Buy → Buy $320
2025-07-25 main Evercore ISI Group Outperform → Outperform $350
2025-07-25 main Barclays Equal-Weight → Equal-Weight $260
2025-06-24 init Barclays — → Equal-Weight $245
2025-03-18 init Evercore ISI Group — → Outperform $275
2025-02-14 main Keybanc Overweight → Overweight $325
2025-01-08 init Citigroup — → Buy $400
2024-12-13 main B of A Securities Buy → Buy $355
2024-12-13 init Wolfe Research — → Peer Perform —
News
RSS: Latest WST news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-20 WITHERSPOON CHARLES Officer and Treasurer — 60 — —
2026-02-20 WINTERS CHAD Officer — 89 — —
2026-02-20 POUSSOT RODOLPHE JEAN Officer — 383 — —
2026-02-18 FAVORITE ANNETTE F Officer — 135 — —
2026-02-18 GREEN ERIC MARK Chief Executive Officer — 1,318 — —
2026-02-18 POUSSOT RODOLPHE JEAN Officer — 82 — —
2026-02-17 FAVORITE ANNETTE F Officer — 441 $0.00 $0
2026-02-17 GREEN ERIC MARK Chief Executive Officer — 4,418 $0.00 $0
2026-02-17 WITHERSPOON CHARLES Officer and Treasurer — 115 $0.00 $0
2026-02-17 WINTERS CHAD Officer — 149 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,074.10
+6.25%
2,893.20
-1.92%
2,949.80
+2.18%
2,886.90
Operating Revenue
3,074.10
+6.25%
2,893.20
-1.92%
2,949.80
+2.18%
2,886.90
Cost Of Revenue
1,970.10
+3.98%
1,894.70
+4.07%
1,820.60
+3.99%
1,750.70
Reconciled Cost Of Revenue
1,970.10
+3.98%
1,894.70
+4.07%
1,820.60
+3.99%
1,750.70
Gross Profit
1,104.00
+10.57%
998.50
-11.57%
1,129.20
-0.62%
1,136.20
Operating Expense
467.90
+14.79%
407.60
-3.37%
421.80
+12.36%
375.40
Research And Development
74.30
+7.53%
69.10
+1.02%
68.40
+16.92%
58.50
Selling General And Administration
393.60
+16.28%
338.50
-4.22%
353.40
+11.52%
316.90
Total Expenses
2,438.00
+5.89%
2,302.30
+2.67%
2,242.40
+5.47%
2,126.10
Operating Income
636.10
+7.65%
590.90
-16.47%
707.40
-7.02%
760.80
Total Operating Income As Reported
584.90
+2.63%
569.90
-15.70%
676.00
-7.90%
734.00
EBITDA
772.80
+3.88%
743.90
-11.89%
844.30
+4.44%
808.40
Normalized EBITDA
822.70
+7.68%
764.00
-12.63%
874.40
+4.43%
837.30
Reconciled Depreciation
171.40
+10.30%
155.40
+13.18%
137.30
+13.85%
120.60
EBIT
601.40
+2.19%
588.50
-16.76%
707.00
+2.79%
687.80
Total Unusual Items
-49.90
-148.26%
-20.10
+33.22%
-30.10
-4.15%
-28.90
Total Unusual Items Excluding Goodwill
-49.90
-148.26%
-20.10
+33.22%
-30.10
-4.15%
-28.90
Special Income Charges
-41.50
-319.19%
-9.90
+52.17%
-20.70
+37.27%
-33.00
Impairment Of Capital Assets
3.70
-47.14%
7.00
+32.08%
5.30
+96.30%
2.70
Restructuring And Mergern Acquisition
33.30
+1180.77%
2.60
+620.00%
-0.50
-101.87%
26.80
Write Off
4.50
+1400.00%
0.30
-93.02%
4.30
-30.65%
6.20
Net Income
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Pretax Income
600.90
+2.63%
585.50
-16.12%
698.00
+2.66%
679.90
Net Non Operating Interest Income Expense
17.00
+2.41%
16.60
-12.63%
19.00
+778.57%
-2.80
Interest Expense Non Operating
0.50
-83.33%
3.00
-66.67%
9.00
+13.92%
7.90
Net Interest Income
17.00
+2.41%
16.60
-12.63%
19.00
+778.57%
-2.80
Interest Expense
0.50
-83.33%
3.00
-66.67%
9.00
+13.92%
7.90
Interest Income Non Operating
17.50
-10.71%
19.60
-30.00%
28.00
+449.02%
5.10
Interest Income
17.50
-10.71%
19.60
-30.00%
28.00
+449.02%
5.10
Other Income Expense
-52.20
-137.27%
-22.00
+22.54%
-28.40
+63.64%
-78.10
Other Non Operating Income Expenses
-2.30
-21.05%
-1.90
-211.76%
1.70
+103.46%
-49.20
Gain On Sale Of Security
-8.40
+17.65%
-10.20
-8.51%
-9.40
-329.27%
4.10
Tax Provision
121.60
+13.12%
107.50
-12.10%
122.30
+6.63%
114.70
Tax Rate For Calcs
0.00
+9.78%
0.00
+5.14%
0.00
+3.55%
0.00
Tax Effect Of Unusual Items
-10.08
-172.54%
-3.70
+29.79%
-5.27
-7.85%
-4.88
Net Income Including Noncontrolling Interests
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Net Income From Continuing Operation Net Minority Interest
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Net Income From Continuing And Discontinued Operation
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Net Income Continuous Operations
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Normalized Income
533.52
+4.80%
509.10
-17.65%
618.23
+1.36%
609.92
Net Income Common Stockholders
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Diluted EPS
6.79
+1.49%
6.69
-15.10%
7.88
+1.94%
7.73
Basic EPS
6.83
+1.19%
6.75
-15.41%
7.98
+1.40%
7.87
Basic Average Shares
72.30
-0.96%
73.00
-1.75%
74.30
-0.13%
74.40
Diluted Average Shares
72.70
-1.36%
73.70
-2.12%
75.30
-0.66%
75.80
Diluted NI Availto Com Stockholders
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Earnings From Equity Interest Net Of Tax
14.40
-2.04%
14.70
-16.95%
17.70
-14.49%
20.70
Gain On Sale Of PPE
0.00
0.00
+100.00%
-11.60
0.00
Other Taxes
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4,270.00
+17.20%
3,643.40
-4.86%
3,829.50
+5.88%
3,616.80
Current Assets
1,978.20
+28.61%
1,538.10
-20.57%
1,936.40
+0.88%
1,919.50
Cash Cash Equivalents And Short Term Investments
791.30
+63.29%
484.60
-43.25%
853.90
-4.52%
894.30
Cash And Cash Equivalents
791.30
+63.29%
484.60
-43.25%
853.90
-4.52%
894.30
Receivables
574.40
+3.96%
552.50
+7.91%
512.00
+0.91%
507.40
Accounts Receivable
574.40
+3.96%
552.50
+7.91%
512.00
+0.91%
507.40
Gross Accounts Receivable
575.80
+4.07%
553.30
+7.90%
512.80
+1.02%
507.60
Allowance For Doubtful Accounts Receivable
-1.40
-75.00%
-0.80
+0.00%
-0.80
-300.00%
-0.20
Inventory
443.90
+17.75%
377.00
-13.27%
434.70
+4.80%
414.80
Raw Materials
163.20
-2.22%
166.90
-3.13%
172.30
+0.94%
170.70
Work In Process
103.20
+58.28%
65.20
-25.32%
87.30
+10.51%
79.00
Finished Goods
177.50
+22.50%
144.90
-17.25%
175.10
+6.06%
165.10
Other Current Assets
168.60
+35.97%
124.00
-8.69%
135.80
+31.84%
103.00
Total Non Current Assets
2,291.90
+8.86%
2,105.40
+11.21%
1,893.10
+11.54%
1,697.30
Net PPE
1,843.40
+9.33%
1,686.10
+11.48%
1,512.50
+19.78%
1,262.70
Gross PPE
3,340.40
+8.09%
3,090.30
+8.92%
2,837.20
+13.90%
2,491.00
Accumulated Depreciation
-1,497.00
-6.61%
-1,404.20
-6.00%
-1,324.70
-7.85%
-1,228.30
Properties
0.00
0.00
0.00
0.00
Land And Improvements
29.20
+4.66%
27.90
-17.21%
33.70
+16.21%
29.00
Buildings And Improvements
1,180.70
+28.88%
916.10
+18.74%
771.50
+16.26%
663.60
Machinery Furniture Equipment
1,577.40
+7.93%
1,461.50
+8.01%
1,353.10
+9.69%
1,233.60
Construction In Progress
256.70
-37.51%
410.80
-1.06%
415.20
+35.73%
305.90
Other Properties
296.40
+8.18%
274.00
+3.91%
263.70
+1.85%
258.90
Goodwill And Other Intangible Assets
117.70
+0.68%
116.90
-5.42%
123.60
-1.67%
125.70
Goodwill
110.00
+3.68%
106.10
-2.21%
108.50
+1.12%
107.30
Other Intangible Assets
7.70
-28.70%
10.80
-28.48%
15.10
-17.93%
18.40
Investments And Advances
212.30
+5.05%
202.10
-3.76%
210.00
+2.49%
204.90
Long Term Equity Investment
212.30
+5.05%
202.10
-3.76%
210.00
+2.49%
204.90
Non Current Deferred Assets
38.40
+47.69%
26.00
+1.17%
25.70
-60.82%
65.60
Non Current Deferred Taxes Assets
38.40
+47.69%
26.00
+1.17%
25.70
-60.82%
65.60
Other Non Current Assets
80.10
+7.81%
74.30
+248.83%
21.30
-44.53%
38.40
Total Liabilities Net Minority Interest
1,094.00
+13.83%
961.10
+1.33%
948.50
+1.78%
931.90
Current Liabilities
654.90
+18.99%
550.40
-18.07%
671.80
+29.44%
519.00
Payables And Accrued Expenses
511.40
+24.34%
411.30
-3.04%
424.20
+8.91%
389.50
Payables
317.60
+4.20%
304.80
+5.76%
288.20
+5.68%
272.70
Accounts Payable
253.70
+6.02%
239.30
-1.28%
242.40
+12.53%
215.40
Dividends Payable
15.80
+3.95%
15.20
+2.70%
14.80
+4.96%
14.10
Current Accrued Expenses
193.80
+81.97%
106.50
-21.69%
136.00
+16.44%
116.80
Employee Benefits
29.00
+2.84%
28.20
-4.73%
29.60
+4.96%
28.20
Pensionand Other Post Retirement Benefit Plans Current
12.00
-4.76%
12.60
+15.60%
10.90
+2.83%
10.60
Total Tax Payable
48.10
-4.37%
50.30
+62.26%
31.00
-28.24%
43.20
Income Tax Payable
28.00
-10.83%
31.40
+89.16%
16.60
-33.06%
24.80
Current Debt And Capital Lease Obligation
22.70
+26.82%
17.90
-88.20%
151.70
+733.52%
18.20
Current Debt
—
—
134.00
+5990.91%
2.20
Other Current Borrowings
—
—
134.00
+5990.91%
2.20
Current Capital Lease Obligation
22.70
+26.82%
17.90
+1.13%
17.70
+10.63%
16.00
Current Deferred Liabilities
51.90
+4.64%
49.60
+18.94%
41.70
-27.23%
57.30
Current Deferred Revenue
51.90
+4.64%
49.60
+18.94%
41.70
-27.23%
57.30
Other Current Liabilities
55.60
-3.14%
57.40
+45.32%
39.50
+23.05%
32.10
Total Non Current Liabilities Net Minority Interest
439.10
+6.92%
410.70
+48.43%
276.70
-32.99%
412.90
Long Term Debt And Capital Lease Obligation
298.40
+4.92%
284.40
+80.80%
157.30
-47.51%
299.70
Long Term Debt
202.80
+0.10%
202.60
+178.30%
72.80
-64.78%
206.70
Long Term Capital Lease Obligation
95.60
+16.87%
81.80
-3.20%
84.50
-9.14%
93.00
Defined Pension Benefit
—
—
—
0.30
Non Current Pension And Other Postretirement Benefit Plans
29.00
+2.84%
28.20
-4.73%
29.60
+4.96%
28.20
Non Current Deferred Liabilities
36.50
+1.67%
35.90
+14.70%
31.30
-6.29%
33.40
Non Current Deferred Taxes Liabilities
23.00
+12.20%
20.50
+61.42%
12.70
-11.19%
14.30
Other Non Current Liabilities
75.20
+20.90%
62.20
+6.32%
58.50
+13.37%
51.60
Stockholders Equity
3,176.00
+18.41%
2,682.30
-6.90%
2,881.00
+7.30%
2,684.90
Common Stock Equity
3,176.00
+18.41%
2,682.30
-6.90%
2,881.00
+7.30%
2,684.90
Capital Stock
18.80
+0.00%
18.80
+0.00%
18.80
+0.00%
18.80
Common Stock
18.80
+0.00%
18.80
+0.00%
18.80
+0.00%
18.80
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
75.34
+0.06%
75.30
+0.00%
75.30
+0.00%
75.30
Ordinary Shares Number
72.04
-0.35%
72.30
-1.63%
73.50
-0.81%
74.10
Treasury Shares Number
3.30
+10.00%
3.00
+66.67%
1.80
+50.00%
1.20
Additional Paid In Capital
0.00
-100.00%
22.10
-81.61%
120.20
-48.23%
232.20
Retained Earnings
4,374.90
+10.57%
3,956.60
+12.29%
3,523.40
+17.93%
2,987.80
Gains Losses Not Affecting Retained Earnings
-105.50
+59.12%
-258.10
-79.49%
-143.80
+21.42%
-183.00
Treasury Stock
1,112.20
+5.21%
1,057.10
+65.79%
637.60
+71.91%
370.90
Other Equity Adjustments
-105.50
+59.12%
-258.10
-79.49%
-143.80
+21.42%
-183.00
Total Equity Gross Minority Interest
3,176.00
+18.41%
2,682.30
-6.90%
2,881.00
+7.30%
2,684.90
Total Capitalization
3,378.80
+17.12%
2,884.90
-2.33%
2,953.80
+2.15%
2,891.60
Working Capital
1,323.30
+33.98%
987.70
-21.90%
1,264.60
-9.70%
1,400.50
Invested Capital
3,378.80
+17.12%
2,884.90
-6.57%
3,087.80
+6.70%
2,893.80
Total Debt
321.10
+6.22%
302.30
-2.17%
309.00
-2.80%
317.90
Capital Lease Obligations
118.30
+18.66%
99.70
-2.45%
102.20
-6.24%
109.00
Net Tangible Assets
3,058.30
+19.21%
2,565.40
-6.96%
2,757.40
+7.74%
2,559.20
Tangible Book Value
3,058.30
+19.21%
2,565.40
-6.96%
2,757.40
+7.74%
2,559.20
Current Provisions
1.30
-18.75%
1.60
-57.89%
3.80
-66.37%
11.30
Foreign Currency Translation Adjustments
—
—
—
-175.40
Interest Payable
12.60
+687.50%
1.60
-38.46%
2.60
+4.00%
2.50
Investmentsin Associatesat Cost
—
—
—
204.90
Minimum Pension Liabilities
—
—
—
-9.40
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
754.80
+15.52%
653.40
-15.85%
776.50
+7.25%
724.00
Cash Flow From Continuing Operating Activities
754.80
+15.52%
653.40
-15.85%
776.50
+7.25%
724.00
Net Income From Continuing Operations
493.70
+0.20%
492.70
-16.97%
593.40
+1.28%
585.90
Depreciation Amortization Depletion
171.40
+10.30%
155.40
+13.18%
137.30
+13.85%
120.60
Depreciation
168.60
+11.07%
151.80
+13.54%
133.70
+14.37%
116.90
Amortization Cash Flow
2.80
-22.22%
3.60
+0.00%
3.60
-2.70%
3.70
Depreciation And Amortization
171.40
+10.30%
155.40
+13.18%
137.30
+13.85%
120.60
Amortization Of Intangibles
2.80
-22.22%
3.60
+0.00%
3.60
-2.70%
3.70
Other Non Cash Items
-2.00
+57.45%
-4.70
-570.00%
1.00
-92.48%
13.30
Pension And Employee Benefit Expense
0.60
+130.00%
-2.00
+20.00%
-2.50
-106.54%
38.20
Stock Based Compensation
23.80
+27.27%
18.70
-19.74%
23.30
-1.69%
23.70
Asset Impairment Charge
11.70
+60.27%
7.30
-23.96%
9.60
+54.84%
6.20
Deferred Tax
-13.70
-291.43%
-3.50
-109.33%
37.50
+221.75%
-30.80
Deferred Income Tax
-13.70
-291.43%
-3.50
-109.33%
37.50
+221.75%
-30.80
Operating Gains Losses
-9.90
+35.71%
-15.40
-196.15%
-5.20
-125.87%
20.10
Gain Loss On Sale Of PPE
0.00
0.00
-100.00%
11.60
0.00
Change In Working Capital
79.80
+2651.72%
2.90
+114.22%
-20.40
-36.00%
-15.00
Change In Receivables
6.90
+111.73%
-58.80
-1570.00%
4.00
+111.24%
-35.60
Changes In Account Receivables
6.90
+111.73%
-58.80
-1570.00%
4.00
+111.24%
-35.60
Change In Inventory
-62.80
-249.52%
42.00
+411.11%
-13.50
+72.89%
-49.80
Change In Payables And Accrued Expense
17.90
+517.24%
2.90
-34.09%
4.40
+257.14%
-2.80
Change In Payable
17.90
+517.24%
2.90
-34.09%
4.40
+257.14%
-2.80
Change In Account Payable
17.90
+517.24%
2.90
-34.09%
4.40
+257.14%
-2.80
Change In Other Working Capital
108.10
+378.32%
22.60
+276.67%
6.00
-89.03%
54.70
Change In Other Current Assets
9.70
+267.24%
-5.80
+72.77%
-21.30
-215.14%
18.50
Investing Cash Flow
-285.90
+24.50%
-378.70
-2.71%
-368.70
-27.93%
-288.20
Cash Flow From Continuing Investing Activities
-285.90
+24.50%
-378.70
-2.71%
-368.70
-27.93%
-288.20
Capital Expenditure
-285.90
+24.16%
-377.00
-4.14%
-362.00
-27.20%
-284.60
Capital Expenditure Reported
-285.90
+24.16%
-377.00
-4.14%
-362.00
-27.20%
-284.60
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Other Investing Changes
—
-1.70
+74.63%
-6.70
-86.11%
-3.60
Financing Cash Flow
-185.10
+70.27%
-622.60
-35.47%
-459.60
-56.54%
-293.60
Cash Flow From Continuing Financing Activities
-185.10
+70.27%
-622.60
-35.47%
-459.60
-56.54%
-293.60
Net Issuance Payments Of Debt
-1.10
+96.01%
-27.60
-1050.00%
-2.40
+94.58%
-44.30
Issuance Of Debt
0.00
-100.00%
164.70
0.00
0.00
Repayment Of Debt
-1.10
+99.43%
-192.30
-7912.50%
-2.40
+94.58%
-44.30
Long Term Debt Issuance
0.00
-100.00%
164.70
0.00
0.00
Long Term Debt Payments
-1.10
+99.43%
-192.30
-7912.50%
-2.40
+94.58%
-44.30
Net Long Term Debt Issuance
-1.10
+96.01%
-27.60
-1050.00%
-2.40
+94.58%
-44.30
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-136.80
+75.86%
-566.60
-25.58%
-451.20
-103.06%
-222.20
Common Stock Payments
-136.80
+75.86%
-566.60
-25.58%
-451.20
-103.06%
-222.20
Cash Dividends Paid
-61.20
-3.55%
-59.10
-3.68%
-57.00
-5.36%
-54.10
Repurchase Of Capital Stock
-136.80
+75.86%
-566.60
-25.58%
-451.20
-103.06%
-222.20
Proceeds From Stock Option Exercised
18.20
-44.34%
32.70
-35.88%
51.00
+80.85%
28.20
Net Other Financing Charges
-4.20
-110.00%
-2.00
-1900.00%
-0.10
+91.67%
-1.20
Changes In Cash
283.80
+181.58%
-347.90
-571.62%
-51.80
-136.43%
142.20
Effect Of Exchange Rate Changes
22.90
+207.01%
-21.40
-287.72%
11.40
+208.57%
-10.50
Beginning Cash Position
484.60
-43.25%
853.90
-4.52%
894.30
+17.27%
762.60
End Cash Position
791.30
+63.29%
484.60
-43.25%
853.90
-4.52%
894.30
Free Cash Flow
468.90
+69.65%
276.40
-33.32%
414.50
-5.67%
439.40
Interest Paid Supplemental Data
0.30
-40.00%
0.50
-91.67%
6.00
-9.09%
6.60
Income Tax Paid Supplemental Data
125.20
+75.35%
71.40
-21.37%
90.80
-17.23%
109.70
Earnings Losses From Equity Investments
-10.50
+21.64%
-13.40
+6.29%
-14.30
+20.99%
-18.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category